Classification
Product TypeIngredient
Product FormPlant extract (standardized liquid concentrate or dried extract powder)
Industry PositionDietary Supplement Ingredient
Market
In the United States, ginseng extract is primarily a demand-side ingredient market serving dietary supplements and other botanical-formulated products. The market is supplied through a mix of imports of standardized extracts and domestic downstream formulation/packaging, with U.S.-native American ginseng mostly relevant through root trade and stewardship controls rather than extract permitting. Market access outcomes are strongly shaped by U.S. FDA oversight for dietary supplements (adulteration/misbranding) and import controls such as prior notice and potential detention actions. Species identity, documentation quality, and contaminant/adulterant controls are critical for reliable clearance and brand acceptance.
Market RoleImport-dependent consumer and supplement ingredient market with domestic downstream formulation and some American ginseng supply chain relevance
Domestic RoleIngredient input for dietary supplement manufacturing and botanical consumer products; domestic activity is concentrated in formulation/packaging and quality testing rather than primary cultivation
Market GrowthNot Mentioned
Specification
Secondary Variety- Panax ginseng (Asian ginseng)
- Panax quinquefolius (American ginseng)
Physical Attributes- Extract form commonly specified as liquid concentrate or dried powder (often with a carrier such as maltodextrin for spray-dried powders).
- Moisture control and low hygroscopicity packaging are emphasized to prevent caking and potency drift.
Compositional Metrics- Standardization and assay expectations often reference marker constituents (e.g., total ginsenosides and/or a ginsenoside profile) with method disclosure.
- Contaminant controls commonly include heavy metals, pesticide residues, residual solvents (if solvent extraction is used), microbiological limits, and adulterant screening.
Grades- Standardized extract (marker-constituent assay declared)
- Organic-certified extract (channel-dependent)
Packaging- Food-grade, tamper-evident packaging suitable for powders or concentrates (e.g., lined drums for bulk powders; HDPE jerry cans for liquids) with lot coding tied to COA.
Supply Chain
Value Chain- Root/biomass sourcing (domestic or imported) → extraction (water/ethanol) → filtration/clarification → concentration → drying (if powder) and blending/standardization → packaging with lot coding → importer/warehouse → manufacturer blending/encapsulation/tableting → finished product distribution
Temperature- Ambient shipment is typical; protect from heat excursions and humidity to preserve extract quality and prevent clumping or degradation.
Shelf Life- Shelf-life performance is closely tied to moisture control, light/oxygen exposure, and stability of declared marker constituents; U.S. buyers commonly expect documented stability and retained samples by lot.
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighU.S. FDA import enforcement (including Import Alerts and detention without physical examination) can block or delay entry of products marketed as foods/dietary supplements when there is evidence of adulteration (e.g., undeclared active pharmaceutical ingredients), misbranding, or inadequate supporting documentation for compliance.Pre-screen the product/supplier against FDA Import Alerts, maintain a complete import dossier (COA, identity/assay methods, GMP documentation), and avoid disease-treatment claims in labeling/marketing materials tied to the shipment.
Documentation Gap MediumIncorrect or inconsistent botanical identity documentation (scientific name/species, plant part, extract form, assay method) can trigger holds, sampling, or relabeling demands at import.Use standardized product naming, include scientific name and plant part on documents, and align COA parameters to purchase specification and label claims.
Supply Chain Integrity MediumBotanical extracts used in supplements face heightened adulteration risk in global trade; U.S. market consequences include recalls, retailer delisting, and regulatory action if adulterants or contaminants are detected.Implement risk-based testing (identity plus adulterant screening and contaminants) and require third-party audits or recognized certification for high-risk suppliers.
Regulatory Compliance MediumLacey Act declaration requirements may apply to certain plant and plant-product imports depending on HTS code scope and entry conditions; missing required plant declarations can result in compliance action or shipment delays.Confirm whether the declared HTS line is covered by APHIS implementation schedules and file accurate plant declaration data (scientific name, country of harvest) when required.
Sustainability- Wild American ginseng overharvest/poaching risk and stewardship expectations in U.S. forests (traceability to legal harvest and age/season compliance where roots are involved)
- Species identity integrity (Panax species differentiation) to prevent misrepresentation and to support legal/ethical sourcing narratives
Labor & Social- Illegal digging and unlicensed trade risks in wild American ginseng supply chains (where U.S.-harvested roots enter upstream supply)
- Supplier audit expectations for ethical sourcing claims in botanicals (channel-dependent)
Standards- USP quality standards and reference standards for dietary supplements and botanicals (buyer-driven)
- NSF/ANSI 173 (third-party certification expectations in some retail and brand programs)
- ISO 22000 / FSSC 22000 (facility-level, buyer-driven)
FAQ
What is the biggest regulatory risk when importing ginseng extract into the United States for supplement use?The biggest risk is U.S. FDA import enforcement: shipments can be detained or refused if FDA believes the product is adulterated or misbranded (for example, if a supplement product contains undeclared drug ingredients) or if the importer cannot support compliance during review. FDA uses Import Alerts for detention without physical examination (DWPE), so screening your product and supplier and keeping a strong compliance dossier is essential.
Does CITES permitting apply to American ginseng extract in the United States?U.S. Fish & Wildlife Service guidance on American ginseng notes that CITES Appendix II controls apply to whole plants, roots, and parts of roots, but the listing excludes powder or manufactured finished products such as teas, capsules, and extracts. Even so, import documentation should clearly describe the form as an extract and support correct species identity to avoid confusion at entry.
What import filings and quality documents are commonly expected for ginseng extract entering the U.S. supply chain?For shipments treated as food/dietary ingredient imports, FDA prior notice is commonly required, and buyers typically expect a lot-specific Certificate of Analysis covering identity and assay/standardization plus contaminant testing. Depending on how the product is classified and scoped, a Lacey Act plant declaration may also be required for certain plant products, and it should include scientific name and country of harvest when applicable.